North American Cell Line Development Market size is anticipated to cross USD 2.9 billion by 2027, according to a latest forecast report by Graphical Research.

Cell line offers numerous growth potential in biologics production, development of viral vaccine and production of biopharmaceutical products to grow North America market.  The use of cell line is mainly in production of recombinant proteins and monoclonal antibodies required for identification and cell culture of single cell clones that are capable to target therapeutic proteins. The use of advanced technology such as flow cytometry, micro-robotics, optics, single cell dispensaries and more had significant impact on cell line development. Flow cytometry use in cell line development to reduce time and increase the work efficiency to deliver accurate results.

The equipment segment is expected to gain around 41% market share in 2020. Equipment are further classified into incubator, centrifuge, bioreactor, storage equipment and microscope. The equipment required for cell line development are specific and it mainly depends on type of research conducted. According to laboratory structure, industry players supply equipment for cell line development, it will allow the researcher to work more efficiently and accurately.  

Browse detailed statistical insights from the report, “North America Cell Line Development Market Forecast 2027 By Source (Mammalian, Non-mammalian {Insects, Amphibians}), By Product (Reagents & Media, Equipment {Incubator, Centrifuge, Bioreactor, Storage Equipment, Microscope}, Accessories & Consumables), By Cell Line (Recombinant, Hybridomas, Continuous Cell Line, Primary Cell Line), By Application (Bioproduction, Drug Discovery, Toxicity Testing, Tissue Engineering, Research), Research Report, Country Outlook (U.S., Canada), COVID-19 Impact Statistics, Price Trends, Historic Data, Growth Prospects, Competitive Industry Share” along with the table of contents (ToC) @

https://www.graphicalresearch.com/industry-insights/1067/north-america-cell-line-development-market

The mammalian segment is dominated more than 71% market share in 2020. Mammalian cell line development is mostly used by biopharmaceutical companies. That are based on methotrexate amplification technology or glutamine synthetase system. CHO (Chinese Hamster Ovary) cells and human embryonic kidney cells are popularly use in production of therapeutic proteins.  

The continuous cell line segment is set to exhibit at over 11% CAGR from 2021 to 2027. Continuous cell line is frequently used because of longer and faster growth of cells. HeLa, BHK21 and Hep2 are some common examples of continuous cell line. Continuous cell line is subculture in plastics surface, suspension and in glass. The cell grows more in suspension conditions. These cells are immortal, transformed, and tumorigenic. Increasing viral vaccine manufacturing and improving research facilities are the major factors that drive segmental growth.  

The drug discovery segment is held around 11.8% market share in 2020. In recent years, increased activities in drug discovery have rapidly increased the demand for cell line development. Cell line development is an important step for examining the efficiency of drug toxicity, discovery and other testing. It reduces the time and cost during testing. Cell lines are derived from cancer cells that are mostly use in research work to identify the new treatments. Increasing demand for new cancer treatment will positively impact on market growth.

The market for cell line development in North America research report includes in-depth coverage of the industry with estimates & forecast in terms of revenue in USD million from 2016 to 2027, for the following segments:

North America Market, By Product

• Reagents & media
• Equipment
  • Incubators
  • Centrifuges
  • Bioreactors
  • Storage equipment
  • Microscopes
• Accessories & Consumables

North America Market, By Source

• Mammalian
• Non-mammalian
  • Insects
  • Amphibians

North America Market, By Cell Line Type

• Recombinant cell lines
• Hybridomas
• Continuous cell lines
• Primary cell lines

North America Market, By Application

• Bioproduction
• Drug discovery
• Toxicity testing
• Tissue engineering
• Research

The above information has been provided for the following countries:

• North America
  • U.S.
  • Canada